Connor, Clark & Lunn Investment Management Ltd. - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$1,844,814
+9.4%
82,542
+5.2%
0.01%
+25.0%
Q2 2023$1,686,879
+68.6%
78,496
+88.3%
0.01%
+60.0%
Q1 2023$1,000,311
+160.5%
41,697
+120.8%
0.01%
+150.0%
Q1 2022$384,000
+180.3%
18,882
+81.6%
0.00%
+100.0%
Q2 2019$137,00010,4000.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$51,452,0001.44%
Camber Capital Management LP 2,000,000$39,480,0001.22%
Eventide Asset Management 2,629,593$51,908,0000.68%
GREAT POINT PARTNERS LLC 121,342$2,395,0000.56%
RICE HALL JAMES & ASSOCIATES, LLC 753,038$14,865,0000.55%
Values First Advisors, Inc. 41,773$825,0000.53%
CLARK ESTATES INC/NY 183,800$3,628,0000.52%
EMERALD MUTUAL FUND ADVISERS TRUST 710,398$14,023,0000.48%
EMERALD ADVISERS, LLC 590,256$11,652,0000.42%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 68,812$1,358,0000.42%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders